Literature DB >> 21715019

Strain-specific viral distribution and neuropathology of feline immunodeficiency virus.

Craig Miller1, Helle Bielefeldt-Ohmann, Martha MacMillan, Salvador Huitron-Resendiz, Steven Henriksen, John Elder, Susan VandeWoude.   

Abstract

Feline immunodeficiency virus (FIV) is a naturally occurring lentivirus of domestic cats, and is the causative agent of feline AIDS. Similar to human immunodeficiency virus (HIV), the pathogenesis of FIV involves infection of lymphocytes and macrophages, and results in chronic progressive immune system collapse and death. Neuropathologic correlates of FIV infection have not yet been elucidated, and may be relevant to understanding HIV-associated neurologic disease (neuroAIDS). As in HIV, FIV strains have been shown to express differential tendencies towards development of clinical neuroAIDS. To interrogate viral genetic determinants that might contribute to neuropathogenicity, cats were exposed to two well-characterized FIV strains with divergent clinical phenotypes and a chimeric strain as follows: FIV(PPR) (PPR, relatively apathogenic but associated with neurologic manifestations), FIV(C36) (C36, immunopathogenic but without associated neurologic disease), and Pcenv (a chimeric virus consisting of a PPR backbone with substituted C36 env region). A sham inoculum control group was also included. Peripheral nerve conduction velocity, CNS imaging studies, viral loads and hematologic analysis were performed over a 12 month period. At termination of the study (350 days post-inoculation), brain sections were obtained from four anatomic locations known to be involved in human and primate lentiviral neuroAIDS. Histological and immunohistochemical evaluation with seven markers of inflammation revealed that Pcenv infection resulted in mild inflammation of the CNS, microglial activation, neuronal degeneration and apoptosis, while C36 and PPR strains induced minimal neuropathologic changes. Conduction velocity aberrations were noted peripherally in all three groups at 63 weeks post-infection. Pcenv viral load in this study was intermediate to the parental strains (C36 demonstrating the highest viral load and PPR the lowest). These results collectively suggest that (i) 3' C36 genomic elements contribute to viral replication characteristics, and (ii) 5' PPR genomic elements contribute to CNS manifestations. This study illustrates the potential for FIV to provide valuable information about neuroAIDS pathogenesis related to genotype and viral kinetics, as well as to identify strains useful to evaluation of therapeutic intervention.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715019      PMCID: PMC3167954          DOI: 10.1016/j.vetimm.2011.06.006

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  49 in total

1.  Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats.

Authors:  M Podell; K Hayes; M Oglesbee; L Mathes
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-08-15

Review 2.  Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

Authors:  Susanne Kramer-Hämmerle; Ina Rothenaigner; Horst Wolff; Jeanne E Bell; Ruth Brack-Werner
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

Review 3.  p38 MAPK signalling cascades in inflammatory disease.

Authors:  E Herlaar; Z Brown
Journal:  Mol Med Today       Date:  1999-10

4.  Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers.

Authors:  Gavin Ryan; Terence Grimes; Brenda Brankin; Mohamad J E M F Mabruk; Margaret J Hosie; Oswald Jarrett; John J Callanan
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

5.  Cortical cell loss in asymptomatic cats experimentally infected with feline immunodeficiency virus.

Authors:  R B Meeker; B A Thiede; C Hall; R English; M Tompkins
Journal:  AIDS Res Hum Retroviruses       Date:  1997-09-01       Impact factor: 2.205

Review 6.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

Review 7.  From mice to macaques--animal models of HIV nervous system disease.

Authors:  M Christine Zink; Victoria A Laast; Kristi L Helke; Angela K Brice; Sheila A Barber; Janice E Clements; Joseph L Mankowski
Journal:  Curr HIV Res       Date:  2006-07       Impact factor: 1.581

8.  The nervous system in early HIV infection: a prospective study through 7 years.

Authors:  K Samuelsson; R Pirskanen-Matell; S Bremmer; T Hindmarsh; B Y Nilsson; H E Persson
Journal:  Eur J Neurol       Date:  2006-03       Impact factor: 6.089

Review 9.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

10.  Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3.

Authors:  Sohela de Rozières; Christina H Swan; Dennis A Sheeter; Karen J Clingerman; Ying-Chuan Lin; Salvador Huitron-Resendiz; Steven Henriksen; Bruce E Torbett; John H Elder
Journal:  Retrovirology       Date:  2004-11-19       Impact factor: 4.602

View more
  8 in total

1.  HIV and FIV glycoproteins increase cellular tau pathology via cGMP-dependent kinase II activation.

Authors:  Matheus F Sathler; Michael J Doolittle; James A Cockrell; India R Nadalin; Franz Hofmann; Sue VandeWoude; Seonil Kim
Journal:  J Cell Sci       Date:  2022-06-21       Impact factor: 5.235

2.  SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats.

Authors:  Miruthula Tamil Selvan; Sachithra Gunasekara; Ping Xiao; Kristen Griffin; Shannon R Cowan; Sai Narayanan; Akhilesh Ramachandran; Darren E Hagen; Jerry W Ritchey; Jennifer M Rudd; Craig A Miller
Journal:  Viruses       Date:  2022-06-01       Impact factor: 5.818

3.  Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence.

Authors:  Maria J Polyak; Pornpun Vivithanaporn; Ferdinand G Maingat; John G Walsh; William Branton; Eric A Cohen; Rick Meeker; Christopher Power
Journal:  FASEB J       Date:  2013-04-22       Impact factor: 5.191

Review 4.  Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Authors:  Christopher Power
Journal:  J Neurovirol       Date:  2017-12-15       Impact factor: 2.643

Review 5.  The molecular biology of feline immunodeficiency virus (FIV).

Authors:  Julia C Kenyon; Andrew M L Lever
Journal:  Viruses       Date:  2011-11-09       Impact factor: 5.048

Review 6.  Feline immunodeficiency virus latency.

Authors:  Samantha J McDonnel; Ellen E Sparger; Brian G Murphy
Journal:  Retrovirology       Date:  2013-07-06       Impact factor: 4.602

Review 7.  Applications of the FIV Model to Study HIV Pathogenesis.

Authors:  Craig Miller; Zaid Abdo; Aaron Ericsson; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2018-04-20       Impact factor: 5.048

8.  Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence.

Authors:  Craig Miller; Jordan Powers; Esther Musselman; Ryan Mackie; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2019-08-30       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.